BeOne Medicines
ONC
#704
Rank
C$45.82 B
Marketcap
C$414.12
Share price
-3.02%
Change (1 day)
65.09%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): C$0.82

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$0.89. In 2024 the company made an earnings per share (EPS) of C-$8.58.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.82-109.5%
2024C-$8.58
2022C-$26.8028.21%
2021C-$20.91-19.96%
2020C-$26.1220.81%
2019C-$21.6231.52%
2018C-$16.44417.57%
2017C-$3.18-37.16%
2016C-$5.05158.95%
2015C-$1.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
C-$1.31-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C-$0.33-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA